AJO LP’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-97,755
| Closed | -$4.15M | – | 667 |
|
2020
Q3 | $4.15M | Sell |
97,755
-40,731
| -29% | -$1.73M | 0.04% | 287 |
|
2020
Q2 | $6.64M | Sell |
138,486
-7,271
| -5% | -$349K | 0.06% | 236 |
|
2020
Q1 | $6.7M | Sell |
145,757
-22,106
| -13% | -$1.02M | 0.06% | 215 |
|
2019
Q4 | $10.1M | Sell |
167,863
-8,884
| -5% | -$534K | 0.06% | 216 |
|
2019
Q3 | $10M | Sell |
176,747
-11,621
| -6% | -$657K | 0.06% | 220 |
|
2019
Q2 | $10.5M | Buy |
188,368
+103,276
| +121% | +$5.75M | 0.05% | 221 |
|
2019
Q1 | $4.3M | Sell |
85,092
-17,241
| -17% | -$870K | 0.02% | 352 |
|
2018
Q4 | $4.12M | Buy |
102,333
+31,373
| +44% | +$1.26M | 0.02% | 341 |
|
2018
Q3 | $4.92M | Buy |
+70,960
| New | +$4.92M | 0.02% | 361 |
|
2018
Q1 | – | Sell |
-63,577
| Closed | -$3.4M | – | 690 |
|
2017
Q4 | $3.4M | Sell |
63,577
-51,320
| -45% | -$2.74M | 0.01% | 379 |
|
2017
Q3 | $6.85M | Buy |
114,897
+35,776
| +45% | +$2.13M | 0.03% | 283 |
|
2017
Q2 | $6.24M | Buy |
79,121
+69,674
| +738% | +$5.5M | 0.03% | 282 |
|
2017
Q1 | $784K | Buy |
+9,447
| New | +$784K | ﹤0.01% | 449 |
|
2015
Q3 | – | Sell |
-47,340
| Closed | -$3.83M | – | 561 |
|
2015
Q2 | $3.83M | Buy |
+47,340
| New | +$3.83M | 0.02% | 335 |
|